Keyphrases
Alzheimer's Disease
61%
Tau Oligomers
58%
Amyloid-β Oligomers
39%
Tauopathy
31%
Neurodegenerative Diseases
26%
Oligomeric
23%
Alpha-synuclein (α-syn)
19%
Tau Aggregates
13%
Neurofibrillary Tangles
12%
Amyloid Protein
10%
Amyloid Fibrils
10%
Tau Aggregation
9%
Neurodegeneration
9%
Alzheimer's Disease Model
9%
Synaptic Dysfunction
8%
Oligomeric tau
8%
Toxic Species
8%
Alzheimer's Disease Brain
8%
Parkinson's Disease
8%
Mouse Model
8%
Brain-inspired
7%
Oligomerization
7%
Monoclonal Antibody
7%
Oligomer Formation
7%
Amyloidosis
7%
Amyloid beta
6%
Pathological tau
6%
Tg2576 Mice
6%
Annular Protofibrils
6%
Alzheimer
5%
Oligomer Toxicity
5%
Plaque
5%
Toxic Oligomers
5%
Transgenic Mice
5%
Passive Immunity
5%
Tau Pathology
5%
Neurodegenerative
5%
Small Molecules
5%
Progressive Supranuclear Palsy
5%
Therapeutic Target
5%
Dementia with Lewy Bodies
5%
Tau Protein
5%
Transgenic Mouse Model
5%
Neuroscience
Oligomer
100%
Alzheimer's Disease
64%
Amyloid
53%
Tauopathy
32%
Neurodegenerative Disorder
21%
Immunotherapy
16%
Synuclein
14%
In Vivo
13%
Neurodegeneration
9%
Amyloidosis
8%
Monoclonal Antibody
7%
Tau Protein
7%
Encephalopathy
7%
Beta Amyloid
7%
In Vitro
6%
Parkinson's Disease
6%
Amyloid Protein
6%
Progressive Supranuclear Palsy
5%
Cognitive Disorders
5%
Dementia with Lewy Bodies
5%
Amnesia
5%
Biochemistry, Genetics and Molecular Biology
Tau
70%
Amyloid
47%
Conformation
15%
Synuclein
15%
Mouse
11%
Monospecific Antibody
9%
Mouse Model
8%
Neurofibrillary Tangle
6%
Small Molecule
5%
Oligomerization
5%